Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedFeb 27, 2024
DataAggregated Company Financials
Companies49
  • 7D2.0%
  • 3M7.7%
  • 1Y9.5%
  • YTD7.4%

Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from Lumosa Therapeutics of 13%. On the other hand Formosa Pharmaceuticals is actually up 8.6%. Over the past 12 months, the industry was up 6.9%. As for the next few years, earnings are expected to grow by 36% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 Feb 2024NT$657.4bNT$101.6bNT$8.2b24.7x80.6x6.5x
Fri, 26 Jan 2024NT$588.9bNT$101.9bNT$7.8b23.7x75.6x5.8x
Sun, 24 Dec 2023NT$580.6bNT$101.6bNT$7.6b23.4x76.1x5.7x
Tue, 21 Nov 2023NT$563.8bNT$101.8bNT$8.4b24.5x67.3x5.5x
Thu, 19 Oct 2023NT$520.3bNT$101.7bNT$9.6b20.1x54.1x5.1x
Sat, 16 Sep 2023NT$555.6bNT$101.7bNT$9.6b22.8x57.7x5.5x
Mon, 14 Aug 2023NT$556.9bNT$97.7bNT$7.9b19.9x70.1x5.7x
Wed, 12 Jul 2023NT$576.1bNT$98.7bNT$10.1b17x57.2x5.8x
Fri, 09 Jun 2023NT$578.5bNT$98.6bNT$10.1b16.8x57.5x5.9x
Sun, 07 May 2023NT$584.4bNT$92.1bNT$8.6b22.3x68.1x6.3x
Tue, 04 Apr 2023NT$569.0bNT$91.5bNT$8.7b20.7x65.8x6.2x
Thu, 02 Mar 2023NT$553.7bNT$84.7bNT$7.6b23.5x72.5x6.5x
Sat, 28 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Mon, 26 Dec 2022NT$505.4bNT$84.6bNT$7.9b23.1x64.1x6x
Wed, 23 Nov 2022NT$452.9bNT$84.6bNT$7.7b16.2x58.8x5.4x
Fri, 21 Oct 2022NT$404.6bNT$78.9bNT$4.3b17x93.5x5.1x
Sun, 18 Sep 2022NT$459.4bNT$78.9bNT$4.3b18.4x106.2x5.8x
Tue, 16 Aug 2022NT$398.5bNT$79.0bNT$5.1b18.4x78.7x5x
Thu, 14 Jul 2022NT$379.8bNT$76.8bNT$4.4b21.4x86.9x4.9x
Sat, 11 Jun 2022NT$388.1bNT$76.8bNT$4.4b21.7x88.8x5.1x
Mon, 09 May 2022NT$385.4bNT$76.5bNT$6.4b21x60.2x5x
Wed, 06 Apr 2022NT$406.3bNT$76.4bNT$6.8b20.6x59.8x5.3x
Fri, 04 Mar 2022NT$407.9bNT$76.5bNT$8.7b20x46.7x5.3x
Sun, 30 Jan 2022NT$378.7bNT$76.7bNT$8.5b18.9x44.7x4.9x
Tue, 28 Dec 2021NT$386.6bNT$76.7bNT$8.5b18.2x45.7x5x
Thu, 25 Nov 2021NT$388.9bNT$76.7bNT$8.5b18.6x45.9x5.1x
Sat, 23 Oct 2021NT$377.7bNT$76.0bNT$10.4b18.4x36.2x5x
Mon, 20 Sep 2021NT$351.5bNT$76.0bNT$10.7b19.2x32.7x4.6x
Wed, 18 Aug 2021NT$346.0bNT$76.0bNT$10.7b21.1x32.2x4.6x
Wed, 02 Jun 2021NT$354.1bNT$74.2bNT$12.5b19.6x28.3x4.8x
Sat, 06 Mar 2021NT$349.2bNT$72.9bNT$8.7b17.5x40.3x4.8x
Price to Earnings Ratio

40.3x


Total Market Cap: NT$349.2bTotal Earnings: NT$8.7bTotal Revenue: NT$72.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 59.8x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 78.7x which is higher than its 3-year average PE of 59.2x.
  • The 3-year average PS ratio of 5.4x is lower than the industry's current PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 2.0% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market1.61%
Healthcare1.93%
Pharma1.99%
Pharma1.99%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1795 Lotus PharmaceuticalNT$296.007.4%
+NT$5.4b
5.3%PE20.2x
6472 Bora PharmaceuticalsNT$672.004.8%
+NT$3.2b
73.5%PE23.7x
6919 Caliway BiopharmaceuticalsNT$513.004.6%
+NT$3.1b
125.0%PS2554.3x
6535 Lumosa TherapeuticsNT$160.0010.3%
+NT$2.5b
273.0%PS499.9x
6838 Formosa PharmaceuticalsNT$62.509.3%
+NT$711.0m
-8.9%PS269x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6838

NT$62.50

Formosa Pharmaceuticals

7D

9.3%

1Y

-8.9%

6919

NT$513.00

Caliway Biopharmaceuticals

7D

4.6%

1Y

125.0%

6932

NT$15.80

Mercury Biopharmaceutical

7D

-6.5%

1Y

-41.5%

6586

NT$63.90

CHO Pharma

7D

-3.5%

1Y

-50.7%

6576

NT$103.50

Foresee Pharmaceuticals

7D

-2.4%

1Y

-1.0%

6785

NT$432.00

Alar Pharmaceuticals

7D

-2.3%

1Y

114.9%

8432

NT$64.30

TSH Biopharm

7D

14.2%

1Y

39.6%

6535

NT$160.00

Lumosa Therapeutics

7D

10.3%

1Y

273.0%

1795

NT$296.00

Lotus Pharmaceutical

7D

7.4%

1Y

5.3%

4743

NT$177.00

Oneness Biotech

7D

-0.6%

1Y

-23.1%

6620

NT$171.00

Handa Pharmaceuticals

7D

-0.9%

1Y

-20.8%

4746

NT$110.50

Formosa Laboratories

7D

4.2%

1Y

53.7%

6472

NT$672.00

Bora Pharmaceuticals

7D

4.8%

1Y

73.5%

1760

NT$103.50

Panion & Bf Biotech

7D

-2.4%

1Y

-35.7%

4123

NT$46.30

Center Laboratories

7D

-0.9%

1Y

7.6%

4166

NT$20.75

Orient Pharma

7D

1.7%

1Y

-9.8%